(IN BRIEF) A major observational study presented at EACVI 2025 found that valvular heart disease is common in patients with prior cancer diagnoses, with 7.2% showing severe disease on echocardiography. Conditions such as tricuspid and mitral regurgitation and aortic stenosis … Read the full press release
Posted in Artificial Intelligence (AI), Austria, Business, Education, France, Healthcare, Industrial, Management, Marketing, News, Non Profit, Pharma & Biotech, Science, Technology
Tagged anthracyclines, Aortic Stenosis, cancer survivors, cardio-oncology, cardiotoxicity, cardiovascular death, Cardiovascular Imaging, CESAR study, EACVI 2025, echocardiography, ESC, European Association of Cardiovascular Imaging, European Society of Cardiology, Maximilian Autherith, mitral regurgitation, mortality risk, New Research Highlights Need for Regular Cardiac Monitoring as Cancer Survivors Face High Rates of Valvular Heart Disease, survival benefit, tricuspid regurgitation, valve intervention, valvular heart disease, Vienna
(IN BRIEF) Researchers at the Fraunhofer Institute for Toxicology and Experimental Medicine and Hannover Medical School have developed an innovative cardiac organoid model that simulates a miniature, functional heart to test the cardiotoxicity of new medications. Comprising heart muscle cells, … Read the full press release
Posted in Business, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged biomedical research, cardiac organoid, cardiotoxicity, drug development, Drug Safety, Fraunhofer, Fraunhofer ITEM, Hannover Medical School, hiPSCs, hypertrophic cardiomyopathy, immune system, induced pluripotent stem cells, macrophages, RNA Therapies
(PRESS RELEASE) SOPHIA ANTIPOLIS CEDEX, France, 12-Apr-2021 — /EuropaWire/ — EuroCMR 2021 will highlight how magnetic resonance imaging (MRI) of the heart helps physicians pinpoint diagnoses and tailor treatment. EuroCMR 2021 will take place on 6 to 8 May online. … Read the full press release
Posted in Artificial Intelligence (AI), Education, France, Healthcare, Internet & Online, News, Pharma & Biotech, Science, Technology
Tagged 3D printing, AI, artificial-intelligence, Cardiac Magnetic Resonance, cardiologists, cardiotoxicity, cardiovascular magnetic resonance congress, chemotherapy, claustrophobic patients, CMR, CMR conference, computed tomography, Computer scientists, congenital heart disease, coronary arteries, COVID-19, CT scans, EACVI, ENDS, engineers, ESC, EuroCMR, EuroCMR 2021, European Association of Cardiovascular Imaging, European Society of Cardiology, Heart, heart attack treatment, heart function, heart muscle, heart problems, hypnosis, ICD, imaging scientists, implantable cardioverter defibrillator, inherited heart conditions, ischaemic heart disease, lymphoma survivors, magnetic resonance imaging, MRI, MRI physicists, myocardial infarction, oedema, Professor Robert Manka, radiographers, Radiologists, stroke, sudden cardiac death
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?